PTPN22 is associated with susceptibility to psoriatic arthritis but not psoriasis: Evidence for a further PSA-specific risk locus

Annals of the Rheumatic Diseases

Volumn 74, Issue 10, 2015, Pages 1882-1885

  Bowes, John ^a   Loehr, Sabine ^b   Budu Aggrey, Ashley ^a,c   Uebe, Steffen ^b   Bruce, Ian N ^a,c   Feletar, Marie ^d   Marzo Ortega, Helena ^e   Helliwell, Philip ^e   Ryan, Anthony W ^f   Kane, David ^g   Korendowych, Eleanor ^h   Alenius, Gerd Marie ⁱ   Giardina, Emiliano ^j   Packham, Jonathan ^k   McManus, Ross ^f   Fitzgerald, Oliver ^l   Brown, Matthew A ^m   Behrens, Frank ⁿ   Burkhardt, Harald ⁿ   McHugh, Neil ^h   Huffmeier, Ulrike ^b   Ho, Pauline ^a,c   Reis, Andre ^b   Barton, Anne ^a,c   more..

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^d MONASH UNIVERSITY   (Australia)

^e UNIVERSITY OF LEEDS   (United Kingdom)

^f TRINITY COLLEGE DUBLIN   (Ireland)

^g ADELAIDE AND MEATH HOSPITAL   (Ireland)

^h University of Bath   (United Kingdom)

ⁱ UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^j TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

^k KEELE UNIVERSITY   (United Kingdom)

^l ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^m UNIVERSITY OF QUEENSLAND   (Australia)

ⁿ GOETHE UNIVERSITY   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; PTPN22 PROTEIN, HUMAN;

ANALYTIC METHOD; ARTICLE; AUSTRALIA; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE PREDISPOSITION; GENE LOCUS; GENE MAPPING; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOME ANALYSIS; GENOTYPE; GERMANY; HUMAN; HUMAN GENOME; IRELAND; MAJOR CLINICAL STUDY; META ANALYSIS (TOPIC); PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; PTPN22 GENE; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SWEDEN; UNITED KINGDOM; VALIDATION PROCESS; CASE CONTROL STUDY; FEMALE; GENETIC PREDISPOSITION; GENETICS; MALE; META ANALYSIS; RISK FACTOR;

ARTHRITIS, PSORIATIC; CASE-CONTROL STUDIES; FEMALE; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 22; PSORIASIS; RISK FACTORS;

EID: 84942865699     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2014-207187     Document Type: Article

References (22)

1. Ibrahim G, Waxman R, Helliwell PS. The prevalence of psoriatic arthritis in people with psoriasis. Arthritis Rheum 2009;61:1373-8.
2. Rosen CF, Mussani F, Chandran V, et al. Patients with psoriatic arthritis have worse quality of life than those with psoriasis alone. Rheumatology (Oxford) 2012;51:571-6.
3. Karason A, Love TJ, Gudbjornsson B. A strong heritability of psoriatic arthritis over four generations-the Reykjavik Psoriatic Arthritis Study. Rheumatology (Oxford) 2009;48:1424-8.
4. Okada Y, Han B, Tsoi LC, et al. Fine mapping major histocompatibility complex associations in psoriasis and its clinical subtypes. Am J Hum Genet 2014;95:162-72. http://www.ncbi.nlm.nih.gov/pubmed/25087609 (accessed 15 Sep. 2014).
5. Bowes J, Budu-Aggrey A, Huffmeier U, et al. Dense genotyping of immune-related susceptibility loci reveals new insights into the genetics of psoriatic arthritis. Nat Commun 2015;6:6046.
6. Strange A, Capon F, Spencer C C A, et al. A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat Genet 2010;42:985-90.
7. Smyth DJ, Plagnol V, Walker NM, et al. Shared and distinct genetic variants in type 1 diabetes and celiac disease. N Engl J Med 2008;359:2767-77.
8. Tsoi LC, Spain SL, Knight J, et al. Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nat Genet 2012;44:1341-8.
9. Eyre S, Bowes J, Diogo D, et al. High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis. Nat Genet 2012;44:1336-40.
10. Han B, Diogo D, Eyre S, et al. Fine mapping seronegative and seropositive rheumatoid arthritis to shared and distinct HLA alleles by adjusting for the effects of heterogeneity. Am J Hum Genet 2014;94:522-32.
11. Gregersen PK, Olsson LM. Recent advances in the genetics of autoimmune disease. Annu Rev Immunol 2009;27:363-91.
12. Stanford SM, Bottini N. PTPN22: the archetypal non-HLA autoimmunity gene. Nat Rev Rheumatol 2014;10:602-11.
13. Butt C, Peddle L, Greenwood C, et al. Association of functional variants of PTPN22 and tp53 in psoriatic arthritis: a case-control study. Arthritis Res Ther 2006;8:R27.
14. Juneblad K, Johansson M, Rantapää-Dahlqvist S, et al. Association between the PTPN22 +1858 C/T polymorphism and psoriatic arthritis. Arthritis Res Ther 2011;13:R45.
15. Hüffmeier U, Reis A, Steffens M, et al. Male restricted genetic association of variant R620W in PTPN22 with psoriatic arthritis. J Invest Dermatol 2006;126:932-5.
16. Hinks A, Barton A, John S, et al. Association between the PTPN22 gene and rheumatoid arthritis and juvenile idiopathic arthritis in a UK population: further support that PTPN22 is an autoimmunity gene. Arthritis Rheum 2005;52:1694-9.
17. Bowes J, Ho P, Flynn E, et al. Comprehensive assessment of rheumatoid arthritis susceptibility loci in a large psoriatic arthritis cohort. Ann Rheum Dis 2012;71:1350-4.
18. Zheng J, Ibrahim S, Petersen F, et al. Meta-analysis reveals an association of PTPN22 C1858T with autoimmune diseases, which depends on the localization of the affected tissue. Genes Immun 2012;13:641-52.
19. Nistor I, Nair RP, Stuart P, et al. Protein tyrosine phosphatase gene PTPN22 polymorphism in psoriasis: lack of evidence for association. J Invest Dermatol 2005;125:395-6.
20. Smith RL, Warren RB, Eyre S, et al. Polymorphisms in the PTPN22 region are associated with psoriasis of early onset. Br J Dermatol 2008;158:962-8.
21. Hüffmeier U, Steffens M, Burkhardt H, et al. Evidence for susceptibility determinant (s) to psoriasis vulgaris in or near PTPN22 in German patients. J Med Genet 2006;43:517-22.
22. Viatte S, Plant D, Bowes J, et al. Genetic markers of rheumatoid arthritis susceptibility in anti-citrullinated peptide antibody negative patients. Ann Rheum Dis 2012;71:1984-90.